PPIA and cancer: This upregulation contributed to drug resistance and diminished chemotherapy outcomes.117 The findings described suggest that CypA plays a role in chemoresistance and/or radioresistance, possibly by influencing the expression of drug resistance-related proteins, causing cell cycle arrest, and activating the MAPK signaling pathways, ultimately leading to unfavorable outcomes in cancer patients.